title: [Fibrinolytic treatment of myocardial infarction. Agents, indications, complications].
authors.affiliation: I Kliniki Kardiologii IK AM, Krakowie.
authors.forename: A M
authors.initials: AM
authors.lastname: Curyło
mesh_terms: D000368:Aged; D016255:Anistreplase / Q000008:administration & dosage; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D016255:Anistreplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator
vernacular_title: Leczenie fibrynolityczne w zawale serca. Leki, wskazania, powikłania.